| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240882 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
The use of oral glutamine may have an important role in the prevention of esophageal complications of concomitant radiochemotherapy in lung cancer patients. However, randomized trials are needed to corroborate that effect. V50 is the dosimetric parameter with better correlation with esophagitis grade and duration.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Manuel M.D., Ph.D., Nuria M.D., Pedro M.D., Martà M.Sc., Palmira M.D., Ph.D., Anna M.D., Jaume M.Sc., Joan M.D., Enric M.Sc., Ismael M.D., Josefa Dengra, Xavier M.D.,